Klothea Bio, Inc.

Amendment
CIK: 0002042705·Other Health Care·DELAWARE·Filed: Feb 2, 2026
Total Offering

$11,130,000

Amount Sold

$2,935,000

Investors

11

First Sale

Oct 11, 2024

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Jeffrey B. Madden
Executive Officer, Director
Agustin Fernandez Santana III
Executive Officer, Director
Olivier Jarry
Executive Officer
Walter Schmidt
Director
Petr Sramek
Director

Company

Klothea Bio, Inc.

195 NW 40TH STREET

MIAMI, FL, 33127

(305) 846-9027

SEC Filing

0002042705-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free